Christina Rossi
Chief Operating Officer bei BLUEPRINT MEDICINES CORPORATION
Vermögen: 6 Mio $ am 31.03.2024
Profil
Christina Rossi is an Independent Director at Xilio Therapeutics, Inc. since 2021.
She is also the Chief Operating Officer at Blueprint Medicines Corp.
since 2018.
Previously, she worked at Genzyme Corp.
from 2012 to 2018 as the Head-Multiple Sclerosis Business Unit.
Prior to that, she was the Head-Commercial Strategy at Eidetica Biopharma GmbH from 2005 to 2010.
Ms. Rossi completed her undergraduate degree at Duke University in 1997 and obtained an MBA from Harvard Business School in 2003.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 07.03.2024 | 64 306 ( 0,11% ) | 6 Mio $ | 31.03.2024 | |
XILIO THERAPEUTICS INC
-.--% | 12.06.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Christina Rossi
| Unternehmen | Position | Beginn |
|---|---|---|
| BLUEPRINT MEDICINES CORPORATION | Chief Operating Officer | 04.04.2022 |
| XILIO THERAPEUTICS, INC. | Director/Board Member | 01.04.2021 |
Ehemalige bekannte Positionen von Christina Rossi
| Unternehmen | Position | Ende |
|---|---|---|
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01.10.2018 |
Eidetica Biopharma GmbH
 Eidetica Biopharma GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Eidetica Biopharma GmbH is a Swiss company that develops and manufactures biopharmaceutical drugs. The private company is based in Zug, Switzerland. | Corporate Officer/Principal | 01.01.2010 |
Ausbildung von Christina Rossi
| Duke University | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BLUEPRINT MEDICINES CORPORATION | Health Technology |
| XILIO THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Eidetica Biopharma GmbH
Eidetica Biopharma GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Eidetica Biopharma GmbH is a Swiss company that develops and manufactures biopharmaceutical drugs. The private company is based in Zug, Switzerland. | Health Technology |
